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Dyslipidemia and Thrombosis: Causal
Relationship or Epiphenomenon of
Sedentary Lifestyle?
To the Editor:
Doggen et al report that low HDL cholesterol and high triglyceride
levels are associated with an increased risk for venous thrombosis in
a population-based case–control study. The authors explain their
results with an interaction of triglycerides with different coagulant
factors as activated protein C (APC), factor VIIc, factor VIII, factor
IX, and fibrinogen.1 However, low HDL cholesterol and high
triglycerides are found frequently in subjects with a predominantly
sedentary lifestyle and are key features of the metabolic syndrome.2
Individuals with the metabolic syndrome are characterized by
prothrombotic hemostatic abnormalities such as elevated plasma
fibrinogen, elevated factor VIIc, and raised concentrations of plas-
minogen activator inhibitor (PAI).3 Regular aerobic exercise leads to
an improved metabolism of serum lipids with increased levels of
HDL cholesterol and decreased plasma triglycerides, resulting in a
lower risk of atherothrombotic events.4 Moreover, a recent publica-
tion shows that moderate-intensity aerobic exercise leads to a
decreased platelet coagulation, hematocrit and blood viscosity, and
PAI 1 antigen.5 All these factors are beneficial to hemostatic balance
and presumably reduce the risk for thromboembolic events. How-
ever, Doggen et al provide no data on physical activity and basic
hematologic parameters such as hematocrit.
We suggest that the reported association of low HDL cholesterol
and hypertriglyceridemia with thrombosis might be explained, be-
sides the pathomechanisms discussed by Doggen et al,1 in part by
lower physical activity resulting in a procoagulant state with in-
creased coagulant factors and higher blood viscosity.
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In response:
We thank the authors for their interest in our study, in which we
describe an increased risk of venous thrombosis in the presence of
low HDL cholesterol and high triglyceride levels.1 Adjustment for
potential confounders, such as weight and height, could only partly
explain the associations. Elevated triglyceride levels in women are
associated with a low activated protein C (APC) ratio and increased
coagulant factors, both of which are known risk factors for venous
thrombosis, therefore potentially clarifying the increased risk with
triglycerides. Unfortunately, we were unable to measure (anti)coag-
ulation or fibrinolytic factors in our study. Besides these mecha-
nisms, Sturm and Sandhofer describe the possibility that lower
physical activity results in a “bad lipid profile,” and suggest that a
procoagulant state and a higher blood viscosity may be additional
explanations. This may indeed be true. However, the role of platelets,
hematocrit, blood viscosity, and the fibrinolytic system in causing a
venous thrombosis has not yet been extensively investigated. One
recent study indicates that plasma hypofibrinolysis constitutes a risk
factor for venous thrombosis.2 We must also keep in mind that
circumstances for a thrombus occurring in an arterial system are
different from those in a venous system, and different risk factors
play a role in both diseases. Although many studies have investigated
the role of physical activity in arterial diseases, the risk of venous
thrombosis has not been studied. The latter is currently under
investigation in a large population-based case–control study, the
“Multiple Environmental and Genetic Assessment of risk factors for
venous thrombosis (MEGA-) Study.”
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